{"data":{"id":"us-sd/sdcl-34-20b-20.2","jurisdiction":"us-sd","citation":"SDCL § 34-20B-20.2","heading":"Xylazine--Permissible uses.","body":"Any material, compound, mixture, or preparation that contains xylazine is a Schedule III controlled drug or substance, except in the following cases:\n(1) Dispensing, prescribing, or administering, to an animal, a drug containing xylazine that has been approved by the United States secretary of health and human services under 21 U.S.C. § 360b (January 1, 2024);\n(2) Dispensing, prescribing, or administering xylazine to an animal that is permissible under 21 U.S.C. § 360b(a)(4) (January 1, 2024);\n(3) Manufacturing, distributing, or using xylazine as an active pharmaceutical ingredient for manufacturing an animal drug:\n(a) Approved under 21 U.S.C. § 360b (January 1, 2024); or\n(b) Issued an investigation use exemption under 21 U.S.C. § 360b(j) (January 1, 2024);\n(4) Manufacturing, distributing, or using a xylazine bulk chemical for pharmaceutical compounding by a licensed pharmacist or veterinarian; or\n(5) Any other use approved or permissible under 21 U.S.C. § 301, et seq. (January 1, 2024).","path":["TITLE 34. PUBLIC HEALTH AND SAFETY","CHAPTER 34-20B. DRUGS AND SUBSTANCES CONTROL"],"source_url":"https://sdlegislature.gov/Statutes/34-20B-20.2","current_through":"2026-08-31","vintage":"","retrieved_at":"2026-09-03T15:18:57Z","sha256":"b3c47b12100fdf46ebca3f90d3432baa452531c1d5fffc1f40f3c88436f46095","source_id":"us-sd","stale":true,"prev":"us-sd/sdcl-34-20b-20.1","next":"us-sd/sdcl-34-20b-20.3"},"notice":"GroundRules: Original legal text. Not legal advice."}